The Legal Decision That Could Rewrite the Abortion Battle—Again
But in the courts, battles are raging on a near-constant basis. This week, abortion advocates and opponents alike have their eyes trained on Texas, where a federal court presided over by a Donald Trump–appointed judge could soon move to block the distribution of mifepristone, an FDA-approved medication used in first-trimester abortions. Mifepristerone is one of two medications used to induce a medication abortion; last month, the FDA issued guidance allowing certified retail pharmacies to distribute the drug for the first time.
Read more at The Atlantic
Advocacy groups brace for looming decision that could end abortion pill access
Doctors and reproductive rights advocates are bracing for a decision in a court case that, if successful, could end legal access to abortion pills nationwide.
Abortion pills have become one of the next major fronts in the fight over reproductive health care in the wake of the Supreme Court’s decision overturning Roe v. Wade, and the lawsuit is seen by both sides as the start of the battle to come.
Read more at The Hill
In lawsuit challenging FDA approval of abortion pills, state attorneys general weigh in
On Friday, New York Attorney General Letitia James led a coalition of 22 attorneys general in filing a brief that argued that if the FDA were ordered to rescind its approval of mifepristone, that would have “devastating consequences” for women across the U.S., regardless of their state’s abortion policy.
Read more at NBC News